Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athina Christopoulou

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Clinical Nuclear Medicine|April 10, 2024
Ablative Radioembolization (SIRT) of a Large Inoperable Renal Cell Carcinoma Invading the Liver That Resulted in Hematuria Control and Complete Necrosis by mRECIST CriteriaIoannis Spyridonidis, Platon Dimopoulos, Trifon Spyridonidis, et al.
Journal of the Turkish German Gynecological Association|August 1, 2019
Secondary debulking for ovarian carcinoma relapse: The R-R dilemma – is the prognosis different for residual or recurrent disease?John D. Spiliotis, Christos Iavazzo, Nikolaos D. Kopanakis, et al.
Annals of Surgical Oncology|September 27, 2005
Hepatic resection at a major community-based teaching hospital can result in good outcomeJohn Spiliotis, Athanassios Rogdakis, Anastassios C Datsis, et al.
Pleura and Peritoneum|August 22, 2020
Survey on the current gynaecological approach of ovarian cancer patients: The utility of HIPECChristos Iavazzo, Alexandros Fotiou, M Tsiatas, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 26, 2021
Mitomycin-C versus oxaliplatin during cytoreductive surgery and HIPEC for peritoneal metastases secondary to colorectal carcinoma: a retrospective analysisJohn Spiliotis, Vasileios Kalles, Anastasia Prodromidou, et al.
Pleura and Peritoneum|December 5, 2019
CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: The small-bowel PCI score as a predictor of survivalJohn Spiliotis, Vasileios Kalles, Ioannis Kyriazanos, et al.
Cancers|April 12, 2022
PARP-1 Expression and <i>BRCA1</i> Mutations in Breast Cancer Patients' CTCsThodoris Sklias, Vasileios Vardas, Evangelia Pantazaka, et al.
Cancers|April 13, 2023
Immune Checkpoint and EMT-Related Molecules in Circulating Tumor Cells (CTCs) from Triple Negative Breast Cancer Patients and Their Clinical ImpactVasileios Vardas, Anastasios Tolios, Athina Christopoulou, et al.
Mediterranean Journal of Rheumatology|July 18, 2020
Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective studyDimitrios Daoussis, Konstantinos Melissaropoulos, Theodoros Dimitroulas, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2014
Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)Filippos Koinis, Aristidis Polyzos, Athina Christopoulou, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Clinical Nuclear Medicine|April 10, 2024
Ablative Radioembolization (SIRT) of a Large Inoperable Renal Cell Carcinoma Invading the Liver That Resulted in Hematuria Control and Complete Necrosis by mRECIST CriteriaIoannis Spyridonidis, Platon Dimopoulos, Trifon Spyridonidis, et al.
Journal of the Turkish German Gynecological Association|August 1, 2019
Secondary debulking for ovarian carcinoma relapse: The R-R dilemma – is the prognosis different for residual or recurrent disease?John D. Spiliotis, Christos Iavazzo, Nikolaos D. Kopanakis, et al.
Annals of Surgical Oncology|September 27, 2005
Hepatic resection at a major community-based teaching hospital can result in good outcomeJohn Spiliotis, Athanassios Rogdakis, Anastassios C Datsis, et al.
Pleura and Peritoneum|August 22, 2020
Survey on the current gynaecological approach of ovarian cancer patients: The utility of HIPECChristos Iavazzo, Alexandros Fotiou, M Tsiatas, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 26, 2021
Mitomycin-C versus oxaliplatin during cytoreductive surgery and HIPEC for peritoneal metastases secondary to colorectal carcinoma: a retrospective analysisJohn Spiliotis, Vasileios Kalles, Anastasia Prodromidou, et al.
Pleura and Peritoneum|December 5, 2019
CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: The small-bowel PCI score as a predictor of survivalJohn Spiliotis, Vasileios Kalles, Ioannis Kyriazanos, et al.
Cancers|April 12, 2022
PARP-1 Expression and <i>BRCA1</i> Mutations in Breast Cancer Patients' CTCsThodoris Sklias, Vasileios Vardas, Evangelia Pantazaka, et al.
Cancers|April 13, 2023
Immune Checkpoint and EMT-Related Molecules in Circulating Tumor Cells (CTCs) from Triple Negative Breast Cancer Patients and Their Clinical ImpactVasileios Vardas, Anastasios Tolios, Athina Christopoulou, et al.
Mediterranean Journal of Rheumatology|July 18, 2020
Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective studyDimitrios Daoussis, Konstantinos Melissaropoulos, Theodoros Dimitroulas, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2014
Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)Filippos Koinis, Aristidis Polyzos, Athina Christopoulou, et al.
Pageof 5